X4 Pharmaceuticals, Inc. (XFOR) has a consensus analyst rating of Buy, based on 13 analysts covering the stock. Of those, 12 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for XFOR is $10.00, representing a +138.1% upside from the current price of $4.2. Price targets range from a low of $10.00 to a high of $10.00.
